ResMed management check

RMD · Health Care · Health Care Equipment · CEO Michael J. Farrell

Filings as of

63
Management score, ranked 284th of 487 · 33rd of 60 in Health Care4 good · 2 to watch · 1 flaggedStrongest: stable leadership · Weakest: clean books · Best and worst run in Health Care →

The seven checks

  • Watch

    Have owners done well?

    Trailed its chosen peersOwners$79Peers$82

    What $100 became since fiscal 2022

    4551st
    Detail

    $100 invested at the start of fiscal 2022 grew to $79, against $82 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20222026

    Pay actually paid $100 value, each on its own scale

    9274th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.85 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    1.1% of net income

    $16.2m pay · $1.5bn net income, FY2026

    0.1%1%3%10%
    4848th
    Detail

    $16.2m of reported pay in fiscal 2026, against $1.5bn of net income.

  • Good

    Do they own the stock?

    CEO stake ≈ 6.9 years of pay

    476,419 shares ≈ $111.5m

    0.1y1y5y20y100y

    6 mo: ▲ $0 bought · ▼ $8.7m sold

    7778th
    Detail

    The CEO holds 476,419 shares, directly or through trusts (unvested awards not counted): about 6.9 years of pay. Light activity: no buys, $8.7m sold in six months. 10 of 10 sales ran on pre-arranged 10b5-1 plans.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 146m2025 · 147m

    Diluted shares −0.0% a year; flagged above +2%

    0%10%20%

    Stock pay 1.8% of revenue

    5036th
    Detail

    Diluted shares changed -0.0% a year over the last three fiscal years. Stock-based pay was 1.8% of revenue in the latest year.

  • Good

    Is leadership stable?

    6 leadership filings in 3 years

    6 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Mr. Michael Farrell

    9575th
    Detail

    CEO in the pay table: Mr. Michael Farrell. 6 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Flag

    Are the books clean?

    Red flags on file

    Since 2021

    • 0Restated
    • 1Auditor changes
    • 0Late filings
    • 010-K amended
    307th
    Detail

    1 auditor change (8-K 4.01) since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed October 1, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
−$6.8m$11.4m$29.6m$10020222023202420252026$79$82

Pay tied most to Adjusted Net Sales

Other key measuresAdjusted Net Operating ProfitTotal Shareholder Return (absolute TSR)Relative Total Shareholder Return (relative TSR)

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2026Mr. Michael Farrell$16.2m−$6.8m$3.6m$79$82$1.5bn
2025Mr. Michael Farrell$14.7m$29.6m$3.4m$105$104$1.4bn
2024Mr. Michael Farrell$14.1m$10.3m$3.1m$78$93$1.0bn
2023Mr. Michael Farrell$13.9m$16.9m$4.1m$89$94$898.0m
2022Mr. Michael Farrell$11.7m$4.4m$3.6m$85$84$779.0m

Insiders and the CEO's stakeQuiet

Chairman and CEO
Michael J. Farrell
Shares held
476,419
At that filing's price
≈ $111.5m
Latest Form 4
Nov 11, 2026

Light activity: no buys, $8.7m sold in six months. 10 of 10 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldMichael J. FarrellChairman and CEO · 10b5-1 plan$6.5mNov 9, 2026
  • SoldPeter C FarrellDirector · 10b5-1 plan$2.0mSep 2, 2026
  • SoldMichael J RiderGlobal General Counsel · 10b5-1 plan$102kOct 23, 2026
  • SoldWitte Jan DeDirector · 10b5-1 plan$102kNov 17, 2026

Leadership and governance on file

20222023202420252026Leadership 11Red flags 1Votes 5
All 12 filings

Latest shareholder vote results: Nov 20, 2025, including the say-on-pay vote.

Where the money went

2021–2025: $1.8bn returned to owners in buybacks and dividends, 39% of net income, and $372.2m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$700.5m$1.4bn20212022202320242025Shares146m147m147m148m147m
Show the figures
Fiscal year20212022202320242025
Revenue$3.2bn$3.6bn$4.2bn$4.7bn$5.1bn
Net income$474.5m$779.0m$898.0m$1.0bn$1.4bn
Stock-based pay$63.9m$65.3m$71.1m$80.2m$91.7m
Buybacks—$0$0$150.0m$300.0m
Dividends$226.7m$245.3m$258.3m$282.3m$310.9m
Diluted shares146m147m147m148m147m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.